Thrombosis

Clinical Studies Further Validates Screening Test

Published in Blood Weekly, June 14th, 2001

American Biogenetic Sciences, Inc. (MABA) reports that three recent studies presented at international medical conferences provide promising data for additional clinical applications of its Thrombus Precursor Protein (TpP^TM) test.

Overall, the studies illustrate that the TpP test's early detection of elevated levels of the thrombus precursor protein may result in the identification of patients suffering from blood clots. The clots could be indicative of a number of medical conditions ranging from heart attack to disorders of the blood system, including thrombophilias, a propensity for the blood to form dangerous clots. Previously published studies...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-06-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry